HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

NCT05493332 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: HAIC(FOLFOX)
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Fluorouracil
DRUG: Toripalimab
DRUG: Donafenib

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University